Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS)
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Life sciences
More from NICE
Home
NICE guidance
Topic prioritisation
Topic prioritisation
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic prioritisation
Filter
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Decision date
Decision date
From date
To date
Apply date filters
Prioritisation programme
Prioritisation programme
HealthTech (4)
Medicines evaluation (3)
None selected (372)
Decision
Decision
Awaiting decision (51)
Further information required (26)
Not selected (298)
Apply filters
Showing 111 to 120 of 379
Sort by
Decision date
Title
Apply sorting
Topic prioritisation
Title
Prioritisation programme
Decision
Decision date
Cefepime–enmetazobactam for treating hospital-acquired pneumonia, including ventilator-associated pneumonia TS ID 12035
None selected
Not selected
4 July 2024
Telmisartan–amlodipine–indapamide for untreated hypertension TS ID 12034
None selected
Not selected
24 June 2024
Human normal immunoglobulin for preventing infection in chronic lymphocytic leukaemia [TSID12043]
None selected
Not selected
21 June 2024
IgPro20 for treating dermatomyositis [TSID12014]
None selected
Not selected
13 June 2024
Subcutaneous nivolumab for treating advanced renal cell carcinoma after systemic treatment TSID 12008
None selected
Not selected
6 June 2024
Basal insulin icodec–semaglutide for treating type 2 diabetes inadequately controlled with daily basal insulin [TSID11940]
None selected
Not selected
6 June 2024
High linear energy transfer radiation for carbon ion beam therapy
None selected
Further information required
30 May 2024
Letermovir for preventing cytomegalovirus infection in people under 18 years after allogeneic haematopoietic stem cell transplant [TS ID 11868]
None selected
Not selected
28 May 2024
Mepolizumab for treating chronic obstructive pulmonary disease with eosinophil-associated exacerbations TSID12019
None selected
Not selected
23 May 2024
Subcutaneous amivantamab for treating advanced non-small-cell lung cancer with EGFR mutations [TSID12011]
None selected
Not selected
21 May 2024
Previous page
1
…
10
11
Current page
12
13
14
…
38
Page
12
of
38
Next page
Results per page
10
25
50
All
Back to top